Skip to main content
Livermore
Livermore
ZHEN

Crewe Advisors LLC

SEC CIK
0001730033
Latest filing
Jul 23, 2026

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by Crewe Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings

Shares (Q2 2026)
1,999
Value
$94.0K
% of portfolio
<0.1%
Quarters held
17
Since Q2 2022
Holdings of DFTX by Crewe Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,999$94.0K<0.1%00.0%UnchangedHolders
Q1 20261,999$37.8K<0.1%00.0%UnchangedHolders
Q4 20251,999$26.8K<0.1%00.0%UnchangedHolders
Q3 20251,999$23.6K<0.1%00.0%UnchangedHolders
Q2 20251,999$13.0K<0.1%00.0%UnchangedHolders
Q1 20251,999$11.7K<0.1%00.0%UnchangedHolders
Q4 20241,999$13.9K<0.1%00.0%UnchangedHolders
Q3 20241,999$11.4K<0.1%00.0%UnchangedHolders
Q2 20241,999$14.4K<0.1%00.0%UnchangedHolders
Q1 20241,999$18.8K<0.1%00.0%UnchangedHolders
Q4 20231,999$7.32K<0.1%00.0%UnchangedHolders
Q3 20231,999$6.26K<0.1%00.0%UnchangedHolders
Q2 20231,999$7.14K<0.1%00.0%UnchangedHolders
Q1 20231,999$6.34K<0.1%00.0%UnchangedHolders
Q4 20221,999$4.40K<0.1%00.0%UnchangedHolders
Q3 20221,999$7.00K<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q2 202229,985$19.0K<0.1%+29,985NewHolders